RETA
Reata Pharmaceuticals Inc
SVP, Global Regulatory Affairs Andrea Loewen sold $160K of Reata Pharmaceuticals Inc
Sold$160,209
$88.08Price
1,819Shares
−4%Stake
What RETA did after the filing
- The stock from Mon, Mar 6 close, $88.51
- +12.0%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Apr 18 close.
Traded Thu, Mar 2. Filed Mon, Mar 6, 11:44 AM ET, during the session. Returns use the Mar 6 close and the Apr 18 close. Not investment advice.